161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
Latest Articles
Study compares tuberculosis infection and disease progression rates in a prospective manner

Study compares tuberculosis infection and disease progression rates in a prospective manner

byBoston University School of MedicineCredit: Unsplash/CC0 Public DomainMycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), is distinct from most germs in its capacity to sil

Study compares tuberculosis infection and disease progression rates in a prospective manner

byBoston University School of MedicineCredit: Unsplash/CC0 Public DomainMycobacterium tuberculosis, the bacteria that causes tuberculosis (TB), is distinct from most germs in its capacity to sil
Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Study links key gene to protection from severe illness and death from COVID infections in men under age 75

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro

Study links key gene to protection from severe illness and death from COVID infections in men under age 75

by David March,NYU Langone HealthGraphical Abstract. Credit:The Journal of Infectious Diseases(2024). DOI: 10.1093/infdis/jiae031A certain variant of a key anti-inflammatory gene pro
Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science

Experimental therapeutic reduces advanced-stage influenza viral loads faster than current therapies in preclinical study

by Steve Martin,Purdue UniversityAn Eradivir employee conducts research on the company's EV25 influenza therapeutic. Research published inProceedings of the National Academy of Science
COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant

by Washington University School of MedicineCredit: Pixabay/CC0 Public DomainPeople who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors—a class of immunosuppressants used
Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the

Mutations do not predict the severity of current variants of SARS-CoV-2, finds study

byUniversity of North Carolina at CharlotteThe fragment antigen-binding region of the neutralizing antibody CV2.1169, shown on the left in red, in complex with the receptor binding domain of the
Chlamydia vaccine shows promise in early trial

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre

Chlamydia vaccine shows promise in early trial

by Robin FosterA chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is curre
T-cell abnormalities in severe COVID-19 cases

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed
Bartonella and Babesia co-infection detected in patients with chronic illness

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study

Bartonella and Babesia co-infection detected in patients with chronic illness

by Tracey Peake,North Carolina State UniversityPhotographs taken by the parents of a rapid onset, homogeneous, non-pruritic red rash on the upper left arm (arrows) in a 2.5-year-old girl (study